The Diagnostic and Prognostic Roles of Combined Expression of Novel Biomarkers in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: An Immunohistochemical Study

BACKGROUND & OBJECTIVE: Diagnosis and discrimination of lung adenocarcinoma (LUAD) from lung squamous cell carcinoma (LUSC) is critical to select the appropriate treatment regimen as recently targeted therapies require accurate subtyping of nonsmall-cell lung carcinoma (NSCLCs). There are curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Alabiad, Mohamed Ali, Harb, Ola A., Abozaid, Mohamed, Embaby, Ahmed, Mandour, Doaa, Hemeda, Rehab, Shalaby, Amany Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Society of Pathology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085294/
https://www.ncbi.nlm.nih.gov/pubmed/33936227
http://dx.doi.org/10.30699/IJP.2020.130944.2452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085294/
https://www.ncbi.nlm.nih.gov/pubmed/33936227
http://dx.doi.org/10.30699/IJP.2020.130944.2452

Ejemplares similares